Török F - Search Results

1

A Novel De Novo Gain-of-Function CACNA1D Variant in Neurodevelopmental Disease With Congenital Tremor, Seizures, and Hypotonia.

Dannenberg F, Von Moers A, Bittigau P, Lange J, Wiegand S, Török F, Stölting G, Striessnig J, Motazacker MM, Broekema MF, Schuelke M, Kaindl AM, Scholl UI, Ortner NJ. Dannenberg F, et al. Among authors: torok f. Neurol Genet. 2024 Sep 6;10(5):e200186. doi: 10.1212/NXG.0000000000200186. eCollection 2024 Oct. Neurol Genet. 2024. PMID: 39246741 Free PMC article.

2

Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies.

Török F, Tezcan K, Filippini L, Fernández-Quintero ML, Zanetti L, Liedl KR, Drexel RS, Striessnig J, Ortner NJ. Török F, et al. Hum Mol Genet. 2023 Feb 19;32(5):847-859. doi: 10.1093/hmg/ddac248. Hum Mol Genet. 2023. PMID: 36208199 Free PMC article.

3

Inactivation induced by pathogenic Ca_v1.3 L-type Ca²⁺-channel variants enhances sensitivity for dihydropyridine Ca²⁺ channel blockers.

Török F, Salamon S, Ortner NJ, Fernández-Quintero ML, Matthes J, Striessnig J. Török F, et al. Br J Pharmacol. 2025 Jan;182(1):181-197. doi: 10.1111/bph.17357. Epub 2024 Oct 7. Br J Pharmacol. 2025. PMID: 39370994

4

Proteomic and toxicological analysis of the venom of Micrurus yatesi and its neutralization by an antivenom.

Mena G, Chaves-Araya S, Chacón J, Török E, Török F, Bonilla F, Sasa M, Gutiérrez JM, Lomonte B, Fernández J. Mena G, et al. Among authors: torok f. Toxicon X. 2022 Feb 12;13:100097. doi: 10.1016/j.toxcx.2022.100097. eCollection 2022 Mar. Toxicon X. 2022. PMID: 35243330 Free PMC article.

5

First look into the venom of Roatan Island's critically endangered coral snake Micrurus ruatanus: Proteomic characterization, toxicity, immunorecognition and neutralization by an antivenom.

Lippa E, Török F, Gómez A, Corrales G, Chacón D, Sasa M, Gutiérrez JM, Lomonte B, Fernández J. Lippa E, et al. Among authors: torok f. J Proteomics. 2019 Apr 30;198:177-185. doi: 10.1016/j.jprot.2019.01.007. Epub 2019 Jan 17. J Proteomics. 2019. PMID: 30659935

6

Selective reduction of condensed N-heterocycles using water as a solvent and a hydrogen source.

Cho H, Török F, Török B. Cho H, et al. Among authors: torok f. Org Biomol Chem. 2013 Feb 21;11(7):1209-15. doi: 10.1039/c2ob26903a. Org Biomol Chem. 2013. PMID: 23313913

7

Introduction to spin label electron paramagnetic resonance spectroscopy of proteins.

Melanson M, Sood A, Török F, Török M. Melanson M, et al. Among authors: torok f. Biochem Mol Biol Educ. 2013 May-Jun;41(3):156-62. doi: 10.1002/bmb.20677. Epub 2012 Dec 27. Biochem Mol Biol Educ. 2013. PMID: 23281241 Free article.

8

Full-dose 90Y ibritumomab tiuxetan therapy is safe in patients with prior myeloablative chemotherapy.

Jacobs SA, Vidnovic N, Joyce J, McCook B, Torok F, Avril N. Jacobs SA, et al. Among authors: torok f. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7146s-7150s. doi: 10.1158/1078-0432.CCR-1004-0003. Clin Cancer Res. 2005. PMID: 16203814 Clinical Trial.

9

Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.

Blodgett TM, Ames JT, Torok FS, McCook BM, Meltzer CC. Blodgett TM, et al. Among authors: torok fs. Clin Nucl Med. 2004 Mar;29(3):161-3. doi: 10.1097/01.rlu.0000115654.90324.02. Clin Nucl Med. 2004. PMID: 15162984

10

Single-detector helical CT in PET-CT: assessment of image quality.

Römer W, Chung M, Chan A, Townsend DW, Torok F, McCook B, Federle MP, Avril N. Römer W, et al. Among authors: torok f. AJR Am J Roentgenol. 2004 Jun;182(6):1571-7. doi: 10.2214/ajr.182.6.1821571. AJR Am J Roentgenol. 2004. PMID: 15150012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters